Announcements Trials
Browse Landscape

Phase

Phase NA 13Phase 4 3Phase 1 3Phase 3 2Phase 2/3 2Phase 1/2 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 48INDUSTRY 9OTHER_GOV 2NIH 1FED 1

Study Type

Interventional 2

Sponsor

Conditions

Breast Neoplasms 17Uterine Cervical Neoplasms 11Stomach Neoplasms 11Carcinoma, Non-Small-Cell Lung 11Ovarian Neoplasms 8Neoplasms 8Esophageal Neoplasms 8Carcinoma, Ovarian Epithelial 7Fallopian Tube Neoplasms 6Colorectal Neoplasms 5Recurrence 4Neoplasm Metastasis 4Multiple Myeloma 4Mouth Neoplasms 4Head and Neck Neoplasms 4Esophageal Squamous Cell Carcinoma 4Colonic Neoplasms 4Carcinoma, Hepatocellular 4Rectal Neoplasms 3Nasopharyngeal Carcinoma 3Lymphoma, Non-Hodgkin 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Glioblastoma 3Urinary Bladder Neoplasms 2Prostatic Neoplasms 2Polycystic Ovary Syndrome 2Peripheral Nervous System Diseases 2Melanoma 2Lymphoma, Mantle-Cell 2Lymphoma, Large B-Cell, Diffuse 2

Interventions

Metformin 1Inositol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × OTHER_GOV × Polycystic Ovary Syndrome × Clear all
NCT07323589 2026-01-07

Impact of Myo-Inositol Alone vs Myo-Inositol Plus Metformin on Conception, Adherence, and Tolerability in PCOS

PAEC general hospital

Phase 3 Completed
120 enrolled

Polycystic Ovary Syndrome

NCT02255578 2014-10-02

EPCOS

Sheba Medical Center

Phase 3 Unknown
50 enrolled

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡